Perioperative Outcomes of Simultaneous Colorectal and Liver Resections

NCT ID: NCT05475041

Last Updated: 2022-07-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

766 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-06-30

Study Completion Date

2022-07-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The use of a simultaneous resection in patients with synchronous colorectal liver metastases has increased over the past decades. However, it remains unclear when a simultaneous resection is beneficial and when it should be avoided. The objective of this retrospective study is therefore to compare the outcomes of a simultaneous resection for synchronous colorectal liver metastases in different settings, and to assess which factors are independently associated with unfavorable outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Cancer Metastatic Surgical Procedure, Unspecified

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Minor liver resection

Minor liver resection (\<3 contiguous segments) in the anterolateral segments

No interventions assigned to this group

Technically major liver resection

Minor liver resection (\<3 contiguous segments) in the posterosuperior segments (Segment 1,4a,7,8)

Technically major liver resection

Intervention Type PROCEDURE

Minor liver resection (\<3 contiguous segments) in the posterosuperior segments (segment 1,4a,7,8)

Major liver resection

Major liver resection (3 or more contiguous segments)

Major liver resection

Intervention Type PROCEDURE

Major liver resection (3 or more contiguous segments)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Major liver resection

Major liver resection (3 or more contiguous segments)

Intervention Type PROCEDURE

Technically major liver resection

Minor liver resection (\<3 contiguous segments) in the posterosuperior segments (segment 1,4a,7,8)

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Elective minimally invasive or open simultaneous resection of colorectal cancer and synchronous colorectal liver metastases

Exclusion Criteria

* (Partially) robotic-assisted or thoracoscopic procedures
* First stage of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS)
* Patients that underwent major concurrent procedures
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Amsterdam

OTHER

Sponsor Role collaborator

Universita di Verona

OTHER

Sponsor Role collaborator

Umberto I Mauriziano Hospital Turin

UNKNOWN

Sponsor Role collaborator

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER

Sponsor Role collaborator

IRCCS San Raffaele

OTHER

Sponsor Role collaborator

University Hospital Padua

UNKNOWN

Sponsor Role collaborator

Riuniti Hospital Polytechnic University of Marche Ancona

UNKNOWN

Sponsor Role collaborator

Clinica Universidad de Navarra Pamplona

UNKNOWN

Sponsor Role collaborator

Groeninge Hospital Kortrijk

UNKNOWN

Sponsor Role collaborator

Oslo University Hospital and Institute of Medicine

UNKNOWN

Sponsor Role collaborator

The Queen Elizabeth Hospital

OTHER

Sponsor Role collaborator

Antoine Béclère Hospital Paris

UNKNOWN

Sponsor Role collaborator

Moscow Clinical Research Centre

UNKNOWN

Sponsor Role collaborator

University Hospital of Girona Dr. Josep Trueta

NETWORK

Sponsor Role collaborator

University Hospital Southampton NHS Foundation Trust

OTHER

Sponsor Role collaborator

Università Cattolica del Sacro Cuore-IRCCS Rome

UNKNOWN

Sponsor Role collaborator

Fondazione Poliambulanza Istituto Ospedaliero

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fondazione Poliambulanza Istituto Ospedaliero

Brescia, Lombardy, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

References

Explore related publications, articles, or registry entries linked to this study.

Sijberden JP, Zimmitti G, Conci S, Russolillo N, Masetti M, Cipriani F, Lanari J, Gorgec B, Benedetti Cacciaguerra A, Rotellar F, D'Hondt M, Edwin B, Sutcliffe RP, Dagher I, Efanov M, Lopez-Ben S, Primrose JN, Giuliante F, Spinelli A, Chand M, Alvarez S, Langella S, Nicosia S, Ruzzenente A, Vivarelli M, Cillo U, Aldrighetti L, Jovine E, Ferrero A, Guglielmi A, Besselink MG, Abu Hilal M. Simultaneous resection of colorectal cancer and synchronous liver metastases: what determines the risk of unfavorable outcomes? An international multicenter retrospective cohort study. Int J Surg. 2023 Mar 1;109(3):244-254. doi: 10.1097/JS9.0000000000000068.

Reference Type DERIVED
PMID: 37093069 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NP5467

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.